Nicotinic Agonists
"Nicotinic Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission.
Descriptor ID |
D018722
|
MeSH Number(s) |
D27.505.519.625.120.140.700 D27.505.696.577.120.140.700
|
Concept/Terms |
Nicotinic Agonists- Nicotinic Agonists
- Agonists, Nicotinic
- Nicotinic Agonist
- Agonist, Nicotinic
- Cholinergic Agonist, Nicotinic
- Agonist, Nicotinic Cholinergic
- Nicotinic Cholinergic Agonist
- Cholinergic Agonists, Nicotinic
- Agonists, Nicotinic Cholinergic
- Nicotinic Cholinergic Agonists
|
Below are MeSH descriptors whose meaning is more general than "Nicotinic Agonists".
Below are MeSH descriptors whose meaning is more specific than "Nicotinic Agonists".
This graph shows the total number of publications written about "Nicotinic Agonists" by people in UAMS Profiles by year, and whether "Nicotinic Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2018 | 1 | 0 | 1 | 2017 | 1 | 0 | 1 | 2015 | 1 | 1 | 2 | 2013 | 2 | 1 | 3 | 2011 | 2 | 2 | 4 | 2010 | 3 | 2 | 5 | 2009 | 2 | 2 | 4 | 2008 | 1 | 4 | 5 | 2007 | 4 | 0 | 4 | 2006 | 4 | 3 | 7 | 2005 | 5 | 1 | 6 | 2004 | 1 | 0 | 1 | 2003 | 1 | 0 | 1 | 2002 | 1 | 1 | 2 | 1999 | 1 | 1 | 2 | 1998 | 1 | 0 | 1 | 1997 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Nicotinic Agonists" by people in Profiles over the past ten years.
-
Addicott MA, Sweitzer MM, McClernon FJ. The Effects of Nicotine and Tobacco Use on Brain Reward Function: Interaction With Nicotine Dependence Severity. Nicotine Tob Res. 2019 05 21; 21(6):764-771.
-
Maggio SE, Saunders MA, Baxter TA, Nixon K, Prendergast MA, Zheng G, Crooks P, Dwoskin LP, Slack RD, Newman AH, Bell RL, Bardo MT. Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats. Psychopharmacology (Berl). 2018 05; 235(5):1439-1453.
-
Arger CA, Heil SH, Sigmon SC, Tidey JW, Stitzer ML, Gaalema DE, Durand HJ, Bunn JY, Ruggieri EK, Higgins ST. Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content. Exp Clin Psychopharmacol. 2017 12; 25(6):473-478.
-
Addicott MA, Oliver JA, Joseph McClernon F. Nicotine increases anterior insula activation to expected and unexpected outcomes among nonsmokers. Psychopharmacology (Berl). 2017 Apr; 234(7):1145-1154.
-
Barnoya J, Jin L, Hudmon KS, Schootman M. Nicotine replacement therapy, tobacco products, and electronic cigarettes in pharmacies in St. Louis, Missouri. J Am Pharm Assoc (2003). 2015 Jul-Aug; 55(4):405-12.
-
Shewale AR, Borse MS, Brown JD, Li C. Mental health status of varenicline and bupropion users during a quit attempt compared to current smokers, other quitters, and non-smokers. Drug Alcohol Depend. 2015 Sep 01; 154:132-8.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|